Tuesday, 31 May 2011

Polaronil




Polaronil may be available in the countries listed below.


Ingredient matches for Polaronil



Dexchlorpheniramine

Dexchlorpheniramine maleate (a derivative of Dexchlorpheniramine) is reported as an ingredient of Polaronil in the following countries:


  • Germany

International Drug Name Search

Thursday, 26 May 2011

Nebivolol-ratiopharm




Nebivolol-ratiopharm may be available in the countries listed below.


Ingredient matches for Nebivolol-ratiopharm



Nebivolol

Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Nebivolol-ratiopharm in the following countries:


  • Germany

International Drug Name Search

Wednesday, 25 May 2011

Askorbo rugsties




Askorbo rugsties may be available in the countries listed below.


Ingredient matches for Askorbo rugsties



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Askorbo rugsties in the following countries:


  • Lithuania

International Drug Name Search

Poli-A




Poli-A may be available in the countries listed below.


Ingredient matches for Poli-A



Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Poli-A in the following countries:


  • Japan

International Drug Name Search

Thursday, 19 May 2011

Topiramate-AET




Topiramate-AET may be available in the countries listed below.


Ingredient matches for Topiramate-AET



Topiramate

Topiramate is reported as an ingredient of Topiramate-AET in the following countries:


  • Poland

International Drug Name Search

Wednesday, 18 May 2011

Sinvastatina Tetrafarma




Sinvastatina Tetrafarma may be available in the countries listed below.


Ingredient matches for Sinvastatina Tetrafarma



Simvastatin

Simvastatin is reported as an ingredient of Sinvastatina Tetrafarma in the following countries:


  • Portugal

International Drug Name Search

Friday, 13 May 2011

Diclofenac Denver Farma




Diclofenac Denver Farma may be available in the countries listed below.


Ingredient matches for Diclofenac Denver Farma



Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Denver Farma in the following countries:


  • Argentina

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Denver Farma in the following countries:


  • Argentina

International Drug Name Search

Protamine Sulfate




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0009009-65-8

Therapeutic Category

Antidote: Anticoagulant antagonist

Chemical Name

Protamine sulfate

Foreign Names

  • Protamini sulfas (Latin)
  • Protamin sulfat (German)
  • Sulfate de protamine (French)
  • Sulfato de protamina (Spanish)

Generic Names

  • Protamina solfato (OS: DCIT)
  • Protamine (sulfate de) (OS: DCF)
  • Protamine Sulfate (OS: JAN)
  • Protamine Sulphate (OS: BAN)
  • Protamine (sulfate de) (PH: Ph. Eur. 6)
  • Protamine Sulfate (PH: Ph. Int. 4, USP 32, JP XIV)
  • Protamine Sulphate (PH: BP 2010, Ph. Eur. 6)
  • Protamini sulfas (PH: Ph. Int. 4, Ph. Eur. 6)
  • Protaminsulfat (PH: Ph. Eur. 6)

Brand Names

  • Denpru
    Fada, Argentina


  • Novo Protamine Sulfate
    Mochida, Japan


  • Prosulf
    CP, Malta; CP Pharmaceuticals, Israel; Vantone, Hong Kong; Wockhardt, United Kingdom; Wockhardt, Georgia


  • Prosulf (veterinary use)
    Wockhardt, United Kingdom


  • Prota
    Samarth, India


  • Protamin sulfat
    Galenika, Georgia; Galenika, Romania; Galenika, Serbia


  • Protamina Mayne
    Mayne, Spain


  • Protamina Sulfato Leo
    Pentafarma, Chile


  • Protamina Sulfato
    Bestpharma, Chile


  • Protamine Choay
    Sanofi-Aventis, France


  • Protamine Sulfaat Leo
    Leo, Belgium


  • Protamine Sulfate
    APP, United States; Artex, New Zealand; Kamada, Israel; Leo, Lithuania; Sandoz, Canada; Sanofi-Aventis, Australia


  • Protamine Sulfate-Leo
    Leo, Luxembourg


  • Protamine Sulphate Leo
    Leo, Estonia; Leo, Greece; Leo, Latvia; Leo, Thailand


  • Protamine Sulphate
    Harvester, Taiwan; Leo, Ireland; Sovereign Medical, United Kingdom; UCB Pharma, United Kingdom


  • Protaminsulfat LEO Pharma
    LEO, Sweden


  • Protaminsulfat Leo
    Leo, Iceland; LEO Pharma, Denmark


  • Protaminsulfat
    Leo, Austria; Leo, Norway


  • Siarczan
    Biomed-Warszawa, Poland

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 7 May 2011

Ceftazidime Biogaran




Ceftazidime Biogaran may be available in the countries listed below.


Ingredient matches for Ceftazidime Biogaran



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Ceftazidime Biogaran in the following countries:


  • France

International Drug Name Search

Tuesday, 3 May 2011

Vastazine




Vastazine may be available in the countries listed below.


Ingredient matches for Vastazine



Trimetazidine

Trimetazidine is reported as an ingredient of Vastazine in the following countries:


  • Tunisia

International Drug Name Search

Rocuronium


Pronunciation: roe-kyoor-OH-nee-um
Generic Name: Rocuronium
Brand Name: Zemuron


Rocuronium is used for:

Relaxing muscles during surgery and mechanical breathing.


Rocuronium is a nondepolarizing neuromuscular blocker. It works by blocking nerve impulses to the muscles, resulting in temporary muscle paralysis.


Do NOT use Rocuronium if:


  • you are allergic to any ingredient in Rocuronium

Contact your doctor or health care provider right away if any of these apply to you.



Before using Rocuronium:


Some medical conditions may interact with Rocuronium. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have liver or kidney problems, an acid-base imbalance, an electrolyte disturbance, Lambert-Eaton syndrome, myasthenia gravis, cachexia (weight loss), high blood pressure, or heart problems, or you are debilitated

Some MEDICINES MAY INTERACT with Rocuronium. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Aminoglycosides (eg, gentamicin), clindamycin, cyclosporine, general inhalation anesthetics (eg, halothane), ketamine, lithium, local anesthetics (eg, lidocaine), magnesium salts, polypeptide antibiotic (eg, polymyxin B), procainamide, quinidine, quinine derivatives (eg, quinine), thiazide diuretics (eg, hydrochlorothiazide), trimethaphan, or verapamil because the actions of Rocuronium may be increased, causing severe muscle relaxation progressing to paralysis and breathing problems

  • Carbamazepine, hydantoins (eg, phenytoin), theophyllines, or thiopurines (eg, azathioprine) because the effectiveness of Rocuronium may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rocuronium may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Rocuronium:


Use Rocuronium as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Rocuronium is usually administered as an injection at your doctor's office, hospital, or clinic. Ask your doctor or pharmacist any questions you may have about Rocuronium.

  • If you miss a dose of Rocuronium, contact your doctor immediately.

Ask your health care provider any questions you may have about how to use Rocuronium.



Important safety information:


  • Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Rocuronium. Using Rocuronium alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Use Rocuronium with caution in the ELDERLY because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Rocuronium during pregnancy. If you are or will be breast-feeding while you are using Rocuronium, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Rocuronium:


All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fast or irregular heartbeat.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Rocuronium side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Rocuronium:

Rocuronium is usually handled and stored by a health care provider. If you are using Rocuronium at home, store Rocuronium as directed by your pharmacist or health care provider. Keep Rocuronium out of the reach of children and away from pets.


General information:


  • If you have any questions about Rocuronium, please talk with your doctor, pharmacist, or other health care provider.

  • Rocuronium is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rocuronium. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rocuronium resources


  • Rocuronium Side Effects (in more detail)
  • Rocuronium Use in Pregnancy & Breastfeeding
  • Rocuronium Drug Interactions
  • Rocuronium Support Group
  • 0 Reviews for Rocuronium - Add your own review/rating


  • Rocuronium Prescribing Information (FDA)

  • rocuronium Concise Consumer Information (Cerner Multum)

  • Rocuronium Bromide Monograph (AHFS DI)

  • Zemuron Prescribing Information (FDA)



Compare Rocuronium with other medications


  • Anesthesia

Aleviatin




Aleviatin may be available in the countries listed below.


Ingredient matches for Aleviatin



Phenobarbital

Phenobarbital is reported as an ingredient of Aleviatin in the following countries:


  • Japan

Phenytoin

Phenytoin is reported as an ingredient of Aleviatin in the following countries:


  • Japan

Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Aleviatin in the following countries:


  • Taiwan

International Drug Name Search